Bayer 2Pk- 25 CT Recalled Due to Rodent Exposure in Distribution Center
Gold Star Distribution Inc is recalling Bayer 2Pk- 25 CT nationwide due to insanitary conditions, including rodent exposure and activity, at their distribution center.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving documented insanitary conditions with rodent exposure and activity in a pharmaceutical distribution facility. While no illnesses or hospitalizations have been reported, the presence of actual contamination hazards in a distribution center for a drug product merits a High severity rating.
Plain-English summary
Bayer 2Pk- 25 CT has been recalled nationwide due to Current Good Manufacturing Practice (CGMP) deviations at the distribution center operated by Gold Star Distribution Inc.
The FDA identified insanitary conditions at the distribution center, including evidence of rodent exposure and activity. These conditions could result in product contamination.
Consumers who have purchased Bayer 2Pk- 25 CT should not use any lots that are within their expiry date and were distributed by Gold Star Distribution. Contact Gold Star Distribution Inc or a healthcare provider if you have questions or concerns.
The recalled product
- Product
- Bayer 2Pk- 25 CT
- Manufacturer
- GOLD STAR DISTRIBUTION INC
- Category
- Drug
- Hazard
- rodent-contamination
- insanitary-conditions
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry distributed by Gold Star Distribution.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27